Pathogenicity of Misfolded and Dimeric HLA-B27 Molecules

被引:15
作者
Antoniou, Antony N. [1 ]
Lenart, Izabela [1 ]
Guiliano, David B. [1 ]
机构
[1] UCL, Div Infect & Immun, Ctr Rheumatol, Windeyer Inst Med Sci,Dept Immunol & Mol Pathol, 46 Cleveland St, London W1T 4JF, England
关键词
D O I
10.1155/2011/486856
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The association between HLA-B27 and the group of autoimmune inflammatory arthritic diseases, the spondyloarthropathies (SpAs) which include ankylosing spondylitis (AS) and Reactive Arthritis (ReA), has been well established and remains the strongest association between any HLA molecule and autoimmune disease. The mechanism behind this striking association remains elusive; however animal model and biochemical data suggest that HLA-B27 misfolding may be key to understanding its association with the SpAs. Recent investigations have focused on the unusual biochemical structures of HLA-B27 and their potential role in SpA pathogenesis. Here we discuss how these unusual biochemical structures may participate in cellular events leading to chronic inflammation and thus disease progression.
引用
收藏
页数:9
相关论文
共 76 条
[1]
Schlosstein L., Terasaki P.I., Bluestone R., Pearson C.M., High association of an HL-A antigen, W27, with ankylosing spondylitis, The New England Journal of Medicine, 288, 14, pp. 704-706, (1973)
[2]
Brewerton D.A., Hart F.D., Nicholls A., Caffrey M., James D.C., Sturrock R.D., Ankylosing spondylitis and HL-A 27, The Lancet, 1, 7809, pp. 904-907, (1973)
[3]
Brewerton D.A., Nicholls A., Caffrey M., Walters D., James D.C.O., Acute anterior uveitis and HL-A 27, The Lancet, 2, 7836, pp. 994-996, (1973)
[4]
Antoniou A.N., Powis S.J., Elliott T., Assembly and export of MHC class I peptide ligands, Current Opinion in Immunology, 15, 1, pp. 75-81, (2003)
[5]
Hammer R.E., Maika S.D., Richardson J.A., Tang J.-P., Taurog J.D., Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human <sub>2</sub>m: An animal model of HLA-B27-associated human disorders, Cell, 63, 5, pp. 1099-1112, (1990)
[6]
Taurog J.D., Maika S.D., Satumtira N., Dorris M.L., McLean I.L., Yanagisawa H., Sayad A., Stagg A.J., Fox G.M., O'Brien A.L., Rehman M., Zhou M., Weiner A.L., Splawski J.B., Richardson J.A., Hammer R.E., Inflammatory disease in HLA-B27 transgenic rats, Immunological Reviews, 169, pp. 209-223, (1999)
[7]
Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D.P., McCarthy M.I., Ouwehand W.H., Samani N.J., Todd J.A., Donnelly P., Barrett J.C., Davison D., Easton D., Evans D.M., Leung H.-T., Marchini J.L., Morris A.P., Spencer C.C.A., Tobin M.D., Attwood A.P., Boorman J.P., Cant B., Everson U., Hussey J.M., Jolley J.D., Knight A.S., Koch K., Meech E., Nutland S., Prowse C.V., Stevens H.E., Taylor N.C., Walters G.R., Walker N.M., Watkins N.A., Winzer T., Jones
[8]
Benjamin R., Parham P., Guilt by association: HLA-B27 and ankylosing spondylitis, Immunology Today, 11, 4, pp. 137-141, (1990)
[9]
Mear J.P., Schreiber K.L., Mnz C., Zhu X., Stevanovi S., Rammensee H.G., Rowland-Jones S.L., Colbert R.A., Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies, Journal of Immunology, 163, 12, pp. 6665-6670, (1999)
[10]
Colbert R.A., HLA-B27 misfolding: A solution to the spondyloarthropathy conundrum?, Molecular Medicine Today, 6, 6, pp. 224-230, (2000)